ChadwickD., 1994.Valproate in the treatment of partial epilepsies,Epilepsia 35 S96 -S8
GrünewaldRA,PanayiotopoulosCP, 1993.Juvenile myoclonic epilepsy: a review,Arch Neurol 50 594 -8
BourgeoisB,BeaumanoirA,BlajevB,CruzN,DesplandP,EgliM, 1987.Monotherapy with valproate in primary generalized epilepsies,Epilepsia 28 S8 -S11
KwanP,Brodie MJ, 2001.Effectiveness of first antiepileptic drug,Epilepsia 42 1255 -60
HungCC,ChangWL,HoJL,TaiJJ,HsiehTJ,HuangHC, 2012.Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization,Pharmacogenomics 13 159 -69
KasperaviciuteD,SisodiyaSM, 2009.Epilepsy pharmacogenetics,Pharmacogenomics 10 817 -36
SchmidtD,LöscherW. Drug, 2005.resistance in epilepsy: putative neurobiologic and clinical mechanisms,Epilepsia 46 858 -77
ChanE,LeeHS,HueSS, 2001.Population pharmacokinetics of carbamazepine in Singapore epileptic patients,Br J Clin Pharmacol 51 567 -76
PeruccaP,GilliamFG, 2012.Adverse effects of antiepileptic drugs,Lancet Neurol 11 792 -802
Asadi-PooyaAA,GhetmiriE., 2006.Folic acid supplementation reduces the development of some blood cell abnormalities in children receiving carbamazepine,Epilepsy Behav 8 228 -31
KurulS,ÜnalpA,YisU, 2007.Homocysteine levels in epileptic children receiving antiepileptic drugs,J Child Neurol 22 1389 -92
SenerU,ZorluY,KaraguzelO,OzdamarO,CokerI,TopbasM., 2006.Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6,Seizure 15 79 -85
ShiYW,MinFL,QinB,ZouX,LiuXR,GaoMM, 2012.Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides,B* 1502? Basic Clin Pharmacol Toxicol 111 58 -64
Reynolds E. Vitamin, 2006.B12, folic acid, and the nervous system,Lancet Neurol 5 949 -60
DordevicS,KilibardaV,StojanovicT., 2009.Determination of carbamazepine in serum and saliva samples by high performance liquid chromatography with ultraviolet detection,Vojnosanit Pregl 66 347 -52
BauerL.,McGraw-Hill, 2005.Clinical pharmacokinetics and pharmacodynamics. Pharmacotherapy: a pathophysiologic approach 6th ed, 51 -73
BelcastroV,StrianoP, 2012.Antiepileptic drugs, hyperhomocysteinemia and B-vitamins supplementation in patients with epilepsy,Epilepsy Res 102 1 -7
YingY,LiH,JinJ,LuX,FengP,SunY, 2017.Meta-analysis of the relationship between plasma homocysteine levels and carbamazepine monotherapy in patients with epilepsy,Iran Red Crescent Med J -
MintzerS,SkidmoreCT,SperlingMR, 2012.B-Vitamin deficiency in patients treated with antiepileptic drugs,Epilepsy Behav 24 341 -4
BhosaleUA,LoharkarNR,YegnanarayanR,QuraishiN., 2014.Study of effects of antiepileptic therapy on various biochemical and hematological parameters patients suffering of epilepsy,Int J Basic Clin Pharmacol 3 79 -85
BroshK,MatokI,SheinerE,KorenG,WiznitzerA,GorodischerR, 2010.Teratogenic determinants of first-trimester exposure to antiepileptic medications,J Popul Ther Clin Pharmacol 18 e89 -98
SelhubJ, 1999.Homocysteine metabolism,Annu Rev Nutr 19 217 -46
EbidA-HIM,AhmedMM,MohammedSA, 2007.Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study,Ther Drug Monit 29 305 -12
GabyAR, 2007.Natural approaches to epilepsy,Altern Med Rev 12 9 -